HOME >> BIOLOGY >> NEWS
Joslin awards Victory Medal to New York man living 75 years with type 1 diabetes

Boston -- Joslin Diabetes Center, the global leader in diabetes research, care and education, will present its 22nd Joslin Victory Award Medal this Sunday, Aug. 13, to a New York man for living 75 years with type 1 (insulin-dependent) diabetes. Robert L. Bates of New Windsor, NY, will be awarded the medal at his 80th birthday celebration at the Thayer Hotel at West Point, NY. The hotel coincidentally is commemorating its 80th anniversary.

"Joslin Medal recipients are individuals who have beaten the odds against diabetes, and Robert Bates is certainly no exception," says George L. King, M.D., director of research at Joslin Diabetes Center in Boston. Dr. King will present the medal to Bates on Sunday. "Robert has continued to live a very successful and fulfilling life despite the challenges associated with the disease."

Bates is a retired chief train dispatcher for the Metro North Railroad in New York. He and his wife of more than 52 years, Carol Bates, have four children: Jacquelyn, Betsie, Robert L. Jr., and John W.

"I am grateful to receive the medal and feel a certain amount of pride in the fact that I have beaten the odds. At the time I was diagnosed, life expectancy was not favorable," says Bates. "I am appreciative that I received early training and education at Joslin Clinic and have benefited from ongoing advances in diabetes treatment, which have allowed me to live a full life."

Bates frequently communicated with Elliott P. Joslin, M.D., founder of Joslin Diabetes Center, who began treating Bates after he was diagnosed in 1931 and regularly inquired about his health. If Dr. Joslin did not receive a response, he would write again, once even sending a telegram. These letters dated through 1961 reflect Dr. Joslin's dedication to what is now called outcomes research, gathering evidence to support his medical recommendations and refining his approach to diabetes management.

By living more than 75 years
'"/>

Contact: Jenny Eriksen
jenny.eriksen@joslin.harvard.edu
617-732-2415
Joslin Diabetes Center
9-Aug-2006


Page: 1 2 3

Related biology news :

1. Joslin study indicates insulin receptors play a critical role in promoting islet growth
2. Joslin researchers discover a surprising culprit in the search for causes of diabetic birth defects
3. Joslin study reveals how a specific fat type can protect against weight gain and diabetes
4. Joslin discovers protein that causes blood vessel leakage and swelling with diabetic retinopathy
5. Joslin-led study uncovers role of appetite hormone MCH in insulin production
6. Joslin Diabetes Center study examines insulin pump therapy in adolescents
7. Joslin Diabetes Center in Boston establishes first affiliate in Canada
8. Walgreens and Joslin Diabetes Center form broad alliance to improve diabetes outcomes
9. Joslins new book demystifies nutrition and meal planning for people with diabetes
10. Joslin study refutes recent report that bone marrow can replenish female oocytes
11. Joslin discovers signs of residual islet cell function in people with long-term type 1 diabetes

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/31/2020)... ... 30, 2020 , ... Justin Zamirowski to lead upcoming launches ... focus on Type 2 diabetes and associated comorbidities. , Justin brings over 20 ... classes. As Chief Commercial Officer, Justin will lead Better Therapeutics’ efforts ...
(Date:7/18/2020)... (PRWEB) , ... July 16, 2020 , ... ... that demonstrates the effectiveness of the Invictus Medical Neoasis™ active noise control device ... The study reported that the Neoasis™ device attenuated the alarm sounds from patient ...
(Date:7/10/2020)... ... July 08, 2020 , ... Overcoming Comparability Issues in ... FDAnews Webinar, Wednesday, July 22, 2020 • 1:30 p.m.-3:00 p.m. EDT, https://www.fdanews.com/cellandgenetherapy ... most effective way to complete one? Will the study comply with all FDA ...
Breaking Biology News(10 mins):
(Date:6/28/2020)... ... June 25, 2020 , ... The Indoor Lab, a leading ... Space™ for businesses of all types to ensure cleanliness, distancing and occupancy with its ... A Safe Space™ enabled business will provide a health performance index system that scores ...
(Date:6/28/2020)... ... 25, 2020 , ... Lumeda Inc. (“Lumeda”), a ... the company has entered a license agreement with Roswell Park Comprehensive Cancer Center ... rights to Roswell Park intellectual property surrounding a novel medical device and method ...
(Date:6/23/2020)... ... June 23, 2020 , ... Kerafast Inc. , developers ... announced the availability of the Delta-G-VSV Pseudotyping System for coronavirus research applications. The ... of SARS-CoV-2 viral entry and COVID-19 vaccine effectiveness at just biosafety level 2 ...
(Date:6/23/2020)... ... June 22, 2020 , ... ... an Amniosomes special offer. This includes buy three, get the fourth unit free ... 568-6909. , Amniotic derived exosomes, known as exosomes, have been a game changer ...
Breaking Biology Technology:
Cached News: